PediaMed Clinical Trials | Home  Sitemap  Contact
Skip Navigation Links
Home
Pipeline
Products
News
Investors
Biz Dev
Careers
About


February 22, 2006
PediaMed Successfully Completes Clinical Trial Enrollment to Study New Therapy In Children with Autism

 

VIRAVAN®
The one with built-in kidpliance!

[Download Adobe Acrobat Reader]

Logo [Package Insert] Viravan Suspension
Viravan Suspension is an antihistamine/nasal decongestant combination for oral administration as a suspension.

Each 5 mL (teaspoonful) of the grape-flavored, purple-colored, suspension for oral administration contains: Phenylephrine Tannate 12.5 mg; Pyrilamine Tannate 30 mg;

Adverse events may include drowsiness, sedation, dryness of mucous membranes, and gastrointestinal effects. [Full Prescribing Information]



Viravan Tablets
Viravan Chewable Tablet is an antihistamine/nasal decongestant combination for oral administration as a chewable tablet.

Each chewable tablet in a grape-flavored, dye-free, mottled brown-colored, scored tablet for oral administration contains: Phenylephrine Tannate 25 mg; Pyrilamine Tannate 30 mg;

Adverse events may include drowsiness, sedation, dryness of mucous membranes, and gastrointestinal effects. [Full Prescribing Information]
Logo [Package Insert]



Logo [Package Insert] Viravan-DM Suspension
Viravan-DM Suspension is an antihistamine/nasal decongestant/antitussive combination for oral administration as a suspension.

Each 5 mL (teaspoonful) of the grape-flavored, purple-colored, suspension for oral administration contains: Phenylephrine Tannate 12.5 mg; Pyrilamine Tannate 30 mg; Dextromethorphan Tannate 25 mg;

Adverse events may include drowsiness, sedation, dryness of mucous membranes, and gastrointestinal effects. [Full Prescribing Information]



Viravan-DM Tablets
Viravan-DM Chewable Tablet is an antihistamine/nasal decongestant/antitussive combination for oral administration as a chewable tablet.

Each chewable tablet in a grape-flavored, dye-free, mottled brown-colored, scored tablet for oral administration contains: Phenylephrine Tannate 25 mg; Pyrilamine Tannate 30 mg; Dextromethorphan Tannate 25 mg;

Adverse events may include drowsiness, sedation, dryness of mucous membranes, and gastrointestinal effects. [Full Prescribing Information]
Logo [Package Insert]



NOTE: You will need Adobe Acrobat Reader to view Package Inserts and Full Prescribing Information

[Download Adobe Acrobat Reader]